Life-threatening baby formula shortage requires fast action, Notre Dame expert says
A shortage of baby formula in the United States that for months has been problematic, has become a national crisis in recent weeks with store shelves empty, retailers limiting purchases and parents beginning to panic.
According to Datasembly, the nationwide out-of-stock rate for baby formula now stands at 40 percent.
The Food and Drug Administration (FDA) has granted permission for Abbott Laboratories to partially restart its troubled, shuttered Michigan plant to help alleviate the nationwide shortage and ship previously produced products. Yesterday, (May 11), Abbott announced it could restart production within two weeks.
As a result of the COVID-19 pandemic, consumers have experienced a number of product shortages, but none as critical as baby formula, according to Kaitlin Wowak, associate professor of IT, analytics and operations at the University of Notre Dame’s Mendoza College of Business.
“Over the last few years, we have seen important products in short supply, including toilet paper, hand sanitizer, PPE and ventilators, to name a few, but no product as critical as baby formula,” said Wowak, who specializes in supply chain disruptions, including product shortages. “This is a product shortage issue that needs to be remedied immediately as infant lives hang in the balance.
“Baby formula is a critical product because if parents can’t get it, what do they feed their infants? “There aren’t substitutes for baby formula, which makes product supply issues particularly dangerous to a vulnerable population — infants. Baby formula is made for infants who don’t have a mature immune system, so product quality is of utmost importance and a shortage can cause consumer panic, as parents scramble to get their hands on formula to feed their babies.”
In addition to underlying supply chain issues, Abbott initiated a baby formula recall in February, which is contributing to the shortage.
“Abbott’s baby formula production is reduced and inventory that accumulated along the supply chain is no longer available to consumers, as a result of its recall,” Wowak said. “Abbott restarting production in two weeks will help alleviate the shortage, but it won’t completely solve the issue and there will be a lag before inventory is available to consumers.”
Wowak says other companies that produce baby formula could potentially increase their production capacity to compensate for Abbott’s reduced production, but they also will be at the mercy of supply chain issues restricting their ability to flex production.
“Also, because baby formula is under FDA oversight, not just any company can start producing baby formula in the short-term,” Wowak said. “When we needed more PPE (personal protective equipment), any company producing related products could quickly pivot their operations and start producing masks or other PPE, but that is not the case with baby formula as the regulations around baby formula are much tighter.”
There have been increasing calls for the government to take action, and reports from the FDA indicate it is doing all it can to help address the shortage. Wowak says this particular product shortage mandates fast action.
Contact: Kaitlin Wowak, 574-631-6685, katie.wowak@nd.edu
Latest Faculty & Staff
- There’s no ‘one size fits all’ when it comes to addressing men’s health issues globallyAt a time when health resources are at a premium and need to be wisely allocated, health professionals must find points within men’s lives when it makes the most sense to intervene and advocate for preventive care for promoting better health outcomes. Life transitions such as marriage and fatherhood are often pivotal and crucial intervention points. But just like every man is different, health concerns across global communities differ as well. Research from the University of Notre Dame finds that not all life transitions produce the same health results, and not all men’s global health policies should look the same from one country to another.
- Three Notre Dame faculty named 2024 Guggenheim FellowsBarbara Montero, a professor of philosophy; Gretchen Reydams-Schils, a professor in the Program of Liberal Studies; and Roy Scranton, an associate professor of English and director of the Creative Writing Program and the Environmental Humanities Initiative, are among the 188 scholars, scientists and artists chosen from approximately 3,000 applicants for the fellowship. The Guggenheim Foundation awards these fellowships to outstanding scholars in order to add to the educational, literary, artistic and scientific power of the country.
- Essays on democracy draw attention to critical threats, explore safeguards ahead of Jan. 6Shortly after Jan. 6, 2021, when a mob stormed the U.S. Capitol building, Notre Dame’s Rooney Center for the Study of American Democracy established the January 6th, 2025, Project, which includes 10 Notre Dame faculty who are preeminent scholars of democracy. In an effort to understand the social, political, psychological and demographic factors that led to that troublesome day, the group created a collection of 14 essays aimed at drawing attention to the vulnerabilities in our democratic system and the threats building against it, hoping to create consensus on ways to remedy both problems.
- Carter Snead testifies before US Senate Judiciary CommitteeO. Carter Snead, the Charles E. Rice Professor of Law and director of the de Nicola Center for Ethics and Culture at the University of Notre Dame, offered expert testimony on Wednesday (March 20) before the U.S. Senate Committee on the Judiciary on the current legal landscape following the landmark Supreme Court decision in Dobbs v. Jackson Women’s Health Organization.
- In memoriam: Ronald Weber, American studies professor emeritusRonald Weber, a professor emeritus of American studies at the University of Notre Dame, died March 12 in Valparaiso, Indiana. He was 89.
- Political scientist shares China-Global South expertise with policymakersFor more than a decade, China has invested heavily in the economic development of countries collectively known as the Global South. More recently, China has demonstrated that its ambitions are growing beyond the economic realm and extending into the geopolitical sphere. This shift carries implications not only for the developing countries that are the beneficiaries of China’s investment, but also for the United States and other developed democracies, says Joshua Eisenman, associate professor of politics in the Keough School of Global Affairs.
